Cargando…

Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience

Background: Tyrosine kinase inhibitors (TKIs) have improved progression-free survival in patients with advanced thyroid cancer. So far, few studies have investigated the efficacy of TKIs in a second-line setting. The purpose of our study was to explore the salvage therapy efficacy in patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brilli, Lucia, Dalmiglio, Cristina, Pilli, Tania, Barbato, Filomena, Maino, Fabio, Capezzone, Marco, Cartocci, Alessandra, Castagna, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864191/ https://www.ncbi.nlm.nih.gov/pubmed/33498404 http://dx.doi.org/10.3390/jcm10030384

Ejemplares similares

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients
por: Capezzone, Marco, et al.
Publicado: (2022)

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
por: Capezzone, Marco, et al.
Publicado: (2021)

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer
por: Valerio, Laura, et al.
Publicado: (2023)

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer
por: Cantara, Silvia, et al.
Publicado: (2023)

EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion
por: Castagna, Maria Grazia, et al.
Publicado: (2020)

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy
por: Brilli, L., et al.
Publicado: (2020)

Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy
por: Brilli, Lucia, et al.
Publicado: (2020)

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer
por: Ricci, Claudia, et al.
Publicado: (2023)

Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a “surgical” and a “cytological” series
por: Marzocchi, C., et al.
Publicado: (2021)

Familial non-medullary thyroid cancer: a critical review
por: Capezzone, M., et al.
Publicado: (2020)

The environmental pollution role in increasing the incidence of thyroid cancer in Tuscany (Italy)
por: Cartocci, A, et al.
Publicado: (2023)

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
por: Cantara, Silvia, et al.
Publicado: (2017)

Response to Letter to the Editor from Edmundo Avila-Hipolito: “Long-Term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity”
por: Pilli, Tania, et al.
Publicado: (2020)

Propensity score analysis of overall survival between first‐ and second‐generation EGFR‐TKIs using real‐world data
por: Ito, Kentaro, et al.
Publicado: (2020)

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs
por: Chen, Ying‐Yuan, et al.
Publicado: (2021)

Nodular Thyroid Disease in the Era of Precision Medicine
por: Tumino, Dario, et al.
Publicado: (2020)

Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred
por: Marzocchi, Carlotta, et al.
Publicado: (2021)

Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs
por: Breccia, Massimo, et al.
Publicado: (2014)

High Incidence of Thyroid Cancer in Southern Tuscany (Grosseto Province, Italy): Potential Role of Environmental Heavy Metal Pollution
por: Capezzone, Marco, et al.
Publicado: (2023)

Silent thyroiditis following vaccination against COVID-19: report of two cases
por: Capezzone, M., et al.
Publicado: (2022)

Telomeres and Thyroid Cancer
por: Capezzone, Marco, et al.
Publicado: (2009)

Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone
por: Wang, Yujia, et al.
Publicado: (2021)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

Update on genistein and thyroid: an overall message of safety
por: Marini, Herbert, et al.
Publicado: (2012)

Are TKIs favourable for the elderly with non-small-cell lung cancer?
por: Rossi, Sabrina, et al.
Publicado: (2016)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen, Miaomiao, et al.
Publicado: (2018)

Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R
por: Deng, Wei, et al.
Publicado: (2016)

Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis
por: Xiao, Jian, et al.
Publicado: (2020)

Corrigendum: Update on genistein and thyroid: an overall message of safety
por: Marini, Herbert, et al.
Publicado: (2022)

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients
por: Yan, Han, et al.
Publicado: (2015)

Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
por: Wei, Zhigang, et al.
Publicado: (2017)

Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer
por: Cantara, Silvia, et al.
Publicado: (2010)

Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes
por: Castagna, Luca, et al.
Publicado: (2020)

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
por: Bernardi, Simona, et al.
Publicado: (2019)

Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
por: Li, Qiwen, et al.
Publicado: (2021)

Novel agents and strategies for overcoming EGFR TKIs resistance
por: Niu, Fei-Yu, et al.
Publicado: (2014)

Adjuvant EGFR-TKIs-based therapy: are we ready?
por: Tam, Terence
Publicado: (2020)

Clinical outcomes of WBRT plus EGFR-TKIs versus WBRT or TKIs alone for the treatment of cerebral metastatic NSCLC patients: a meta-analysis
por: Zheng, Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7g98huut27m1dol5vtbmb8adce